An open-label, randomized, parallel-group, multicenter, observational trial to evaluate safety and efficacy of edoxaban tosylate in children from 38 weeks gestational age to less than 18 years of age with cardiac diseases at risk of thromboembolic events

Project: Research project

Project Details

StatusActive
Effective start/end date12/16/198/31/50

Funding

  • Daiichi-Sankyo Pharma Development
  • Daiichi-Sankyo Pharma Development